489477 Sigma-AldrichLSD1 Inhibitor II, S2101 - Calbiochem
LSD1 Inhibitor II, S2101, is a cell-permeable, 2-PCPA derived mechanism-based inhibitor of LSD1 (IC50 = 0.99 µM, KI = 0.61 µM, and kinact/KI = 4560 M-1S-1).
More>> LSD1 Inhibitor II, S2101, is a cell-permeable, 2-PCPA derived mechanism-based inhibitor of LSD1 (IC50 = 0.99 µM, KI = 0.61 µM, and kinact/KI = 4560 M-1S-1). Less<<Synonyms: LSD Inhibitor II, S2101, BHC110 Inhibitor II, Histone Lysine Demethylase Inhibitor IV, KDM1 Inhibitor II, MOA Inhibitor II
Recommended Products
Overview
| Replacement Information |
|---|
Key Spec Table
| Empirical Formula |
|---|
| C₁₆H₁₆ClF₂NO |
Pricing & Availability
| Catalogue Number | Availability | Packaging | Qty/Pack | Price | Quantity | |
|---|---|---|---|---|---|---|
| 489477-5MG |
|
Glass bottle | 5 mg |
|
— |
| Description | |
|---|---|
| Overview | A cell-permeable, 2-PCPA derivative that elicits mechanism-based inhibition against LSD1 (IC50 = 0.99 µM, KI = 0.61 µM, and kinact/KI = 4560 M-1S-1), and displays much lower inhibition activity toward MAO-B (KI = 17 µM, kinact/KI = 18 M-1S-1) and MAO-A (KI = 110 µM, kinact/KI = 60 M-1S-1), with higher potency and selectivity compared with those of 2-PCPA (Cat. No. 616431) (IC50 = 184 µM, KI = 100 µM, kinact/KI = 58 M-1S-1 for LSD1, and K I = 26 µM, kinact/KI = 271 M-1S-1 for MAO-B, and K I = 5 µM, kinact/KI = 1050 M-1S-1 for MAO-A). The inhibition of LSD1 is further confirmed in a cell-based assay, the treatment of HEK293T human cells with S2101 results in a dose-dependent increase in the level of H3K4me2, and about 50-fold stronger inhibition compared with that of 2-PCPA. |
| Catalogue Number | 489477 |
| Brand Family | Calbiochem® |
| Synonyms | LSD Inhibitor II, S2101, BHC110 Inhibitor II, Histone Lysine Demethylase Inhibitor IV, KDM1 Inhibitor II, MOA Inhibitor II |
| References | |
|---|---|
| References | Mimasu, S., et al. 2010. Biochemistry 49, 6494. |
| Product Information | |
|---|---|
| Form | White solid |
| Hill Formula | C₁₆H₁₆ClF₂NO |
| Chemical formula | C₁₆H₁₆ClF₂NO |
| Structure formula Image | |
| Quality Level | MQ100 |
| Applications | |
|---|---|
| Application | LSD1 Inhibitor II, S2101, is a cell-permeable, 2-PCPA derived mechanism-based inhibitor of LSD1 (IC50 = 0.99 µM, KI = 0.61 µM, and kinact/KI = 4560 M-1S-1). |
| Biological Information | |
|---|---|
| Purity | ≥95% by HPLC |
| Physicochemical Information |
|---|
| Dimensions |
|---|
| Materials Information |
|---|
| Toxicological Information |
|---|
| Safety Information according to GHS |
|---|
| Safety Information |
|---|
| Product Usage Statements |
|---|
| Packaging Information |
|---|
| Transport Information |
|---|
| Supplemental Information |
|---|
| Specifications |
|---|
| Global Trade Item Number | |
|---|---|
| Catalogue Number | GTIN |
| 489477-5MG | 04055977273373 |
Documentation
LSD1 Inhibitor II, S2101 - Calbiochem SDS
| Title |
|---|
LSD1 Inhibitor II, S2101 - Calbiochem Certificates of Analysis
| Title | Lot Number |
|---|---|
| 489477 |
References
| Reference overview |
|---|
| Mimasu, S., et al. 2010. Biochemistry 49, 6494. |



